Signals
Cancer Sequencing Becomes the Operating System of Precision Oncology
ASCO 2026 showed how comprehensive genomic solutions are moving from research support to the practical backbone of cancer detection, profiling, monitoring and treatment matching.
Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease
A new Lp(a) threshold could reshape cardiovascular risk assessment
The next cardiometabolic battleground is ultra-processed food
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Oral SERDs Face the Hard Test: Where Do They Actually Fit?
Prostate Cancer Value Starts Counting Cognition
The ASCO Drug Race Still Runs Through Genomic Testing
Alzheimer’s Blood Testing Moves the Disease Clock Earlier
Physical activity continues to strengthen its case as a cross-disease prevention strategy
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.